Lupin Limited informed about the appointment of Dr. Ranjana Pathak as Chief Quality Officer of the Company effective April 3, 2024. Dr. Pathak will oversee all aspects of quality and regulatory compliance for the Company's global operations. Company informed that Mr. Johnny Mikell, President - Global Head of Quality, will be retiring from the services of the Company effective June 30, 2024.

With over three decades of industry experience, Dr. Pathak has a wealth of knowledge and expertise. She will oversee all aspects of quality and regulatory compliance for the Company's global operations. Dr. Pathak's career includes serving as the Global Head for Quality and Pharmacovigilance at Dr. Reddy's. Prior to her tenure at Dr. Reddy's, Dr. Pathak served as the President & Global Head of Quality, Medical Affairs and Pharmacovigilance at Cipla and has also held Global Quality and Compliance leadership positions at Watson/Actavis and Endo Pharmaceuticals in the U.S. Dr. Pathak has strong experience across generic and brand medicines across dosage platforms including injectables, inhalation products and biologics.

Mr. Jonny Mikell headed the Company's Quality and regulatory Compliance function and related processes and practices.